Стриверди Респимат

Стриверди Респимат is an inhaled bronchodilator designed to help manage symptoms of chronic obstructive pulmonary disease (COPD). This long-acting beta-agonist provides sustained relief for breathing difficulties. It is administered via the Respimat inhaler device. Suitable for adults with COPD-related airflow obstruction.

Olodaterol is primarily used to treat symptoms associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It helps open the airways, making it easier to breathe by relaxing the muscles in the lungs. This medication is not intended for acute asthma attacks or sudden breathing problems. It is used as a maintenance therapy to improve daily respiratory function in adults.

Users typically experience improved airflow and reduced wheezing shortly after inhalation. The effects of olodaterol can last up to 24 hours, providing consistent relief throughout the day. Some may notice a reduction in coughing and chest tightness. Individual responses may vary based on lung condition and adherence to the prescribed regimen.

Keep the inhaler clean and dry to ensure proper function. Store at room temperature away from moisture and heat. Avoid exposing the device to extreme cold. Do not share your inhaler with others, as it is prescribed for individual use. If the inhaler appears damaged or the mist changes, consult a healthcare professional before use.

Olodaterol may interact with other inhaled medications, especially those containing long-acting beta-agonists or anticholinergics. Concurrent use with certain heart medications, such as beta-blockers, may reduce effectiveness. Avoid combining with stimulants or excessive caffeine, as these may increase heart rate. Always inform your healthcare provider about all medications being used.